Phase 2 trial with Avastin and Doxorubicin postoperatively for patients with anaplastic thyroid carcinoma
- Conditions
- Patients that suffer from anaplastic thyroid cancer and have completed our standard initial therapy with radiotherapy and chemotherapy, and has been macroscopical radically resected after completion of initial therapy.
- Registration Number
- EUCTR2007-001783-75-SE
- Lead Sponsor
- Department of Oncology, Lund University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
•Verified anaplastic thyroid cancer.
•Completion of standard initial therapy with radiotherapy and chemotherapy
•Surgically resected with macroscopic radicality
•Performance Status ECOG 0-2. If lung metastasis ECOG 0-1
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
•Performance Status ECOG 3-4. If lung metastasis ECOG 2-4
•Macroscopic evident non-radical surgery.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method